Corrigendum to "Biomonitoring Equivalents for Molybdenum" [Regul. Toxicol. Pharmacol. 77 (2016) 223-229]

Regul Toxicol Pharmacol. 2022 Oct:134:105212. doi: 10.1016/j.yrtph.2022.105212. Epub 2022 Jul 20.

Authors

Sean M Hays¹, Kristin Macey², Devika Poddalgoda², Ming Lu², Andy Nong², Lesa L Aylward³

Affiliations

¹ Summit Toxicology, LLP, Lyons, CO, 90540, USA. Electronic address: shays@summittoxicology.com.
² Health Canada, Ottawa, ON, Canada.
³ Summit Toxicology, LLP, Falls Church, VA, 22044, USA.

PMID: 35870961
DOI: 10.1016/j.yrtph.2022.105212

No abstract available

Publication types

Published Erratum